Philips Launches HyperVue Integrated System in the U.S. for Coronary Imaging and Physiology in the Cath Lab
Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System, a new single room-based configuration of its HyperVue Imaging System for DeepOCT+NIRS imaging and X1-FFR physiology assessment. Designed to keep advanced coronary imaging and physiology tools connected and readily available in the interventional suite, the System will be showcased at TCT 2026 in San Diego from October 31 to November 3, alongside Philips’ broader portfolio of imaging, physiology, and procedural guidance solutions for precision PCI.
HyperVue with X1-FFR brings together angiography-derived, drug-free coronary physiology with DeepOCT+NIRS intravascular imaging on a single platform. X1-FFR is an FDA-cleared, AI-powered, angiography-derived platform designed to simplify and speed up FFR results at the patient’s bedside, and Philips described it as the only FDA-cleared angiogram-derived FFR solution to use a single angiographic view rather than two or three to provide an FFR value. Unlike the mobile configuration of the HyperVue Imaging System, which must be brought into the procedure room, powered, and connected for each case, HyperVue Integrated is permanently installed in a dedicated interventional suite, keeping the imaging capability readily available when clinicians need it.
The system provides continuous connectivity in the cath lab for both DeepOCT+NIRS imaging and X1-FFR, with a table-mounted touchscreen enabling bedside system control within the sterile field, and the new configuration introduces updates to the controller to further simplify setup and user experience. By eliminating the need to move, connect, and prepare a mobile system for each procedure, HyperVue Integrated is designed to reduce setup steps and make advanced imaging and physiology more accessible in the everyday cath lab workflow. HyperVue Integrated expands Philips’ coronary guidance portfolio alongside its IVUS and physiology solutions, and at TCT the company will also showcase HyperVue Integrated alongside IntraSight Plus, its U.S.-available interventional guidance platform, which brings IVUS, iFR/FFR physiology, co-registration, tri-registration, and real-time device visualization together in a single platform.
Richard Shlofmitz, MD, Chief of Cardiology at St. Francis Hospital and Heart Center, Catholic Health, said that in a high-volume cath lab, imaging technology needs to be readily available, simple to operate, and easy to use at the point of care. Shlofmitz noted that the team was encouraged by the HyperVue technology and looks forward to continuing its collaboration with Philips to explore how a more integrated workflow can support efficient, patient-focused care.
Stacy Beske, Business Leader of Image Guided Therapy Devices at Philips, said every procedure is an opportunity to help a patient return to a fuller life, and physicians need technology that supports confident clinical decisions without adding unnecessary complexity or time. Beske noted that for advanced intravascular imaging to become part of everyday practice, it has to fit naturally into the high-volume workflow of the interventional suite, and that part of what Philips will showcase at TCT is how this approach extends across its portfolio, bringing imaging, physiology, and procedural guidance closer together so physicians can access the information they need throughout the PCI procedure.
